首页 | 官方网站   微博 | 高级检索  
     

以细胞因子为靶点的抗哮喘药物研究进展
引用本文:蔡鑫君,张相彩,徐颖颖.以细胞因子为靶点的抗哮喘药物研究进展[J].中国临床药理学与治疗学,2010,15(3):350-355.
作者姓名:蔡鑫君  张相彩  徐颖颖
作者单位:浙江省中西医结合医院药剂科,杭州,310003,浙江
摘    要:许多细胞因子在哮喘患者的气道慢性炎症与重构过程中起到关键作用,是抗哮喘药物的重要靶点。本文主要介绍了近年来以细胞因子(白细胞介素类、肿瘤坏死因子、嗜酸性粒细胞活化趋化因子)为靶点的抗哮喘药物最新进展和发展趋势,并就近年来涌现出的一些新的抗哮喘药物的研究进展作一综述。

关 键 词:哮喘  细胞因子  药物治疗

Progress on anti-asthma agents targeted for cytokine
CAI Xin-jun,ZHANG Xiang-cai,XU Ying-ying.Progress on anti-asthma agents targeted for cytokine[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2010,15(3):350-355.
Authors:CAI Xin-jun  ZHANG Xiang-cai  XU Ying-ying
Affiliation:(Department of Pharmacy, Integrated Chinese and Western Medicine Hospital of Zhejiang Province, Hangzhou 310003 , Zhejiang,China)
Abstract:Several cytokines which play key role in asthma patients with chronic inflammation and reconstruction of air duct,are important targets for anti asthma agents. In this review, we summarize the latest advancement of antiasthma agents which targeted for cytokines(interleukins, TNF, eotaxin) and investigation development of new anti-asthma agents emerged in recent years.
Keywords:Asthma  Cytokine  Drug therpy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号